Advancing Biopharmaceutical Manufacturing at the University of Delaware's SABRE Center Amount: $10,000,000 Description: Funds will equip the SABRE Center with advanced manufacturing tools to support U.S. biopharma innovation and small-to-medium manufacturers.
I will seek $10,000,000 in federal Community Project Funding to equip the University of Delaware's SABRE Center with advanced biopharmaceutical manufacturing tools.
Occurrences
Evidence
The FY2026 CJS Community Project Funding/Congressionally Directed Spending table lists: DOC NIST-STRS; Recipient: University of Delaware; Project: Biopharmaceutical Manufacturing Equipment; Location: Newark, DE; Conference Amount: $3,604,000; Requestor(s): McBride, Blunt Rochester, Coons; Origination: H/S.
Public Law 119-74 states it is an Act making consolidated appropriations for fiscal year ending September 30, 2026. It provides that the explanatory statement has the same effect for allocation and implementation, and under NIST Scientific and Technical Research and Services makes $405,331,366 available for NIST-STRS projects in the Community Project Funding/Congressionally Directed Spending table, with those amounts not transferable for other purposes.
The House Appropriations Committee release says the Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 was released as a bipartisan, bicameral conferenced package and that it delivers critical community projects nationwide. The release links to the CJS Community Project Funding document.
Assessments
McBride was listed as a requestor for the University of Delaware biopharmaceutical manufacturing equipment Community Project Funding item, and the FY2026 appropriations law made the incorporated table legally operative during her federal term. However, the enacted amount was $3,604,000, well below the promised $10,000,000, so the core funding objective was only partially achieved.